Loss of connexin43 expression in Ewing's sarcoma cells favors the development of the primary tumor and the associated bone osteolysis.

[1]  R. Shaw,et al.  Multilayered regulation of cardiac ion channels. , 2013, Biochimica et biophysica acta.

[2]  G. Firestone,et al.  Minireview: regulation of gap junction dynamics by nuclear hormone receptors and their ligands. , 2012, Molecular endocrinology.

[3]  M. Ladanyi,et al.  Molecular pathogenesis of Ewing sarcoma: new therapeutic and transcriptional targets. , 2012, Annual review of pathology.

[4]  H. Knowles,et al.  Ewing sarcoma cells express RANKL and support osteoclastogenesis , 2011, The Journal of pathology.

[5]  C. Naus,et al.  Implications and challenges of connexin connections to cancer , 2010, Nature Reviews Cancer.

[6]  Stephen A Bustin,et al.  Why the need for qPCR publication guidelines?--The case for MIQE. , 2010, Methods.

[7]  P. Jedlicka.  Ewing Sarcoma, an enigmatic malignancy of likely progenitor cell origin, driven by transcription factor oncogenic fusions. , 2010, International journal of clinical and experimental pathology.

[8]  Naomi J Balamuth,et al.  Ewing's sarcoma. , 2010, The Lancet. Oncology.

[9]  M. Mesnil,et al.  Gap junctions and cancer: new functions for an old story. , 2009, Antioxidants & redox signaling.

[10]  F. Verrecchia,et al.  TGF‐β induces connexin43 gene expression in normal murine mammary gland epithelial cells via activation of p38 and PI3K/AKT signaling pathways , 2008, Journal of cellular physiology.

[11]  F. Verrecchia,et al.  TNF‐α represses connexin43 expression in hacat keratinocytes via activation of JNK signaling , 2008, Journal of cellular physiology.

[12]  R. Civitelli.  Cell-cell communication in the osteoblast/osteocyte lineage. , 2008, Archives of biochemistry and biophysics.

[13]  T. Nishida,et al.  Establishment of human corneal epithelial cells stably expressing human connexin43. , 2008, Experimental eye research.

[14]  David M. Thomas,et al.  The distinctive biology of cancer in adolescents and young adults , 2008, Nature Reviews Cancer.

[15]  J. Czyż.  The stage-specific function of gap junctions during tumourigenesis , 2007, Cellular & Molecular Biology Letters.

[16]  Nicolò Riggi,et al.  The Biology of Ewing sarcoma. , 2007, Cancer letters.

[17]  O. Delattre,et al.  Mesenchymal stem cell features of Ewing tumors. , 2007, Cancer cell.

[18]  P. Mantyh,et al.  Similarities and Differences in Tumor Growth, Skeletal Remodeling and Pain in an Osteolytic and Osteoblastic Model of Bone Cancer , 2006, The Clinical journal of pain.

[19]  M. Mesnil,et al.  Defective gap junctional intercellular communication in the carcinogenic process. , 2005, Biochimica et biophysica acta.

[20]  J. Thiery,et al.  Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma. , 2005, Bone.

[21]  G. Sosinsky,et al.  Structural organization of gap junction channels. , 2005, Biochimica et biophysica acta.

[22]  W. Hunziker,et al.  Association of ARVCF with zonula occludens (ZO)-1 and ZO-2: binding to PDZ-domain proteins and cell-cell adhesion regulate plasma membrane and nuclear localization of ARVCF. , 2004, Molecular biology of the cell.

[23]  O. Delattre,et al.  EWS/FLI-1 Silencing and Gene Profiling of Ewing Cells Reveal Downstream Oncogenic Pathways and a Crucial Role for Repression of Insulin-Like Growth Factor Binding Protein 3 , 2004, Molecular and Cellular Biology.

[24]  B. Giepmans.  Gap junctions and connexin-interacting proteins. , 2004, Cardiovascular research.

[25]  Michael R Rosen,et al.  Human mesenchymal stem cells make cardiac connexins and form functional gap junctions , 2004, The Journal of physiology.

[26]  J. Ogawa,et al.  Connexin26‐mediated gap junctional communication reverses the malignant phenotype of MCF‐7 breast cancer cells , 2003, Cancer science.

[27]  Y. Iwamoto,et al.  Identification of p21 WAF1/CIP1 as a Direct Target of EWS-Fli1 Oncogenic Fusion Protein* , 2003, The Journal of Biological Chemistry.

[28]  David L. Paul,et al.  Beyond the gap: functions of unpaired connexon channels , 2003, Nature Reviews Molecular Cell Biology.

[29]  Akihiro Umezawa,et al.  Upregulation of Id2, an oncogenic helix-loop-helix protein, is mediated by the chimeric EWS/ets protein in Ewing sarcoma , 2003, Oncogene.

[30]  Toshifumi Ozaki,et al.  Expression analysis of pediatric solid tumor cell lines using oligonucleotide microarrays. , 2002, International journal of oncology.

[31]  C. Naus.  Gap junctions and tumour progression. , 2002, Canadian journal of physiology and pharmacology.

[32]  I. Morita,et al.  Connexin43 suppresses proliferation of osteosarcoma U2OS cells through post-transcriptional regulation of p27 , 2001, Oncogene.

[33]  O. Delattre,et al.  Analysis of the expression of cell cycle regulators in Ewing cell lines: EWS-FLI-1 modulates p57KIP2 and c-Myc expression , 2001, Oncogene.

[34]  D. Welch,et al.  Breast cancer metastatic potential correlates with a breakdown in homospecific and heterospecific gap junctional intercellular communication. , 2001, Cancer research.

[35]  W. May,et al.  PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors , 2001, Oncogene.

[36]  A. Zallone,et al.  Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts. , 2000, Biochemical and biophysical research communications.

[37]  V. Krutovskikh,et al.  Differential effect of subcellular localization of communication impairing gap junction protein connexin43 on tumor cell growth in vivo , 2000, Oncogene.

[38]  P. Sorensen,et al.  Repression of the gene encoding the TGF-β type II receptor is a major target of the EWS-FLI1 oncoprotein , 1999, Nature Genetics.

[39]  F. Verrecchia,et al.  ATP counteracts the rundown of gap junctional channels of rat ventricular myocytes by promoting protein phosphorylation , 1999, The Journal of physiology.

[40]  T. Steinberg,et al.  Cyclic Stretch Enhances Gap Junctional Communication Between Osteoblastic Cells , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  J. Going,et al.  Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours , 1998, The Journal of pathology.

[42]  F. Verrecchia,et al.  Reversible inhibition of gap junctional communication by tamoxifen in cultured cardiac myocytes , 1997, Pflügers Archiv.

[43]  B F Boyce,et al.  Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. , 1996, The Journal of clinical investigation.

[44]  N. Gilula,et al.  The Gap Junction Communication Channel , 1996, Cell.

[45]  F. Verrecchia,et al.  Reversible Interruption of Gap Junctional Communication by Testosterone Propionate in Cultured Sertoli Cells and Cardiac Myocytes , 1996, The Journal of Membrane Biology.

[46]  C. Naus,et al.  A pre-loading method of evaluating gap junctional communication by fluorescent dye transfer. , 1995, BioTechniques.

[47]  C. Denny,et al.  Multiple domains mediate transformation by the Ewing's sarcoma EWS/FLI-1 fusion gene. , 1995, Oncogene.

[48]  M. Roussel,et al.  DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma , 1994, Molecular and cellular biology.

[49]  G. Williams,et al.  Cell culture assays for chemicals with tumor-promoting or tumor-inhibiting activity based on the modulation of intercellular communication , 1994, Cell Biology and Toxicology.

[50]  G. Fishman,et al.  Functional analysis of the connexin43 gene promoter in vivo and in vitro. , 1994, Journal of molecular and cellular cardiology.

[51]  C. Denny,et al.  Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[52]  G. Thomas,et al.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours , 1992, Nature.

[53]  J. Bechberger,et al.  Expression of gap junction genes in astrocytes and C6 glioma cells , 1991, Neuroscience Letters.

[54]  J. Thiery,et al.  Chromosomes in Ewing's sarcoma. I. An evaluation of 85 cases of remarkable consistency of t(11;22)(q24;q12). , 1988, Cancer genetics and cytogenetics.

[55]  G. Mundy,et al.  Modulation of type beta transforming growth factor activity in bone cultures by osteotropic hormones. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[56]  C. Naus,et al.  Gap junction proteins on the move: connexins, the cytoskeleton and migration. , 2013, Biochimica et biophysica acta.

[57]  A. Balmain,et al.  Cell‐cell communication and growth control of normal and cancer cells: Evidence and hypothesis , 1993 .